Title: RST DLMP Grand Rounds: CSF and Blood-Based Biomarkers of Alzheimer’s Disease, September 4, 2024

Speakers: Alicia Algeciras-Schimnich, Ph.D. and Joshua Bornhorst, Ph.D.

Learning Objectives: After attending this presentation, you should be able to:

• Define the current criteria for Alzheimer’s Disease Diagnosis
• Discuss the role of fluid biomarkers (both blood and CSF) for diagnosing Alzheimer’s disease
• Recognize the importance of assay performance measures when evaluating fluid biomarkers for Alzheimer’s disease

Audience: DLMP Staff

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.